Rating Change
Truist Securities analysts reiterated a Buy rating on SI-BONE, Inc. (NASDAQ:SIBN) on July 16, 2026.
reiterateNASDAQ:SIBN
Truist Securities Reiterates Buy Rating on SI-BONE, Inc. (SIBN)
Rating Change Truist Securities analysts reiterated a Buy rating on SI-BONE, Inc. (NASDAQ:SIBN) on July 16, 2026. Market Context SI-BONE, Inc.
Market Context
SI-BONE, Inc. operates in the Healthcare sector. The stock currently trades at $17.72 with a market capitalization of $816.6M. The stock has gained 4.7% over the past 52 weeks.
Analyst coverage from Truist Securities provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for SI-BONE, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for SI-BONE, Inc.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 16, 2026 | Truist Securities | Buy | N/A |
| May 12, 2026 | TD Cowen | Buy | N/A |
| May 12, 2026 | Truist Securities | Buy | N/A |
| Apr 15, 2026 | Truist Securities | Buy | N/A |
| Feb 24, 2026 | Truist Securities | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View SIBN Stock Page
Frequently Asked Questions
What does a Buy rating mean for SIBN?
A Buy rating from Truist Securities reflects the analyst's outlook on SI-BONE, Inc. (NASDAQ:SIBN). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the SIBN forecast page.